Tuvonralimab, CAS 2417649-44-4

Product Description: Tuvonralimab (PSB-205; QL1706) is a dual immune checkpoint blockade containing a mixture of anti-PD-1 IgG4 and anti-CTLA-4 IgG1 antibodies, Iparomlimab and Tuvonralimab[1].

Applications: Cancer-programmed cell death

Formula: N/A

References: [1]Ian Wilkinson, et al. Systematic analysis of the varied designs of 819 therapeutic antibodies and Fc fusion proteins assigned international nonproprietary names. MAbs. 2022 Jan-Dec;14(1):2123299.

CAS Number: 2417649-44-4

Molecular Weight: N/A

Compound Purity: 99.14

Research Area: Cancer

Solubility: 10 mM in DMSO

Target: CTLA-4;PD-1/PD-L1

• Artikelnummer: MEXHY-P99540-5
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99540-5
• Verpackungseinheit: 5 mg
• Mengeneinheit: STK
• Konjugat: Unconjugated